RxNorm Semantic Concepts Index - 321
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "321".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 321 | 3',5'-cyclic AMP synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 321 | 3',5'-cyclic AMP synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 321 | 3',5'-cyclic AMP synthetase | Designated preferred name (PT) | NO | |
| RxCUI: 321 | 3',5'-cyclic AMP synthetase | Full form of descriptor (FN) | NO | |
| RxCUI: 321 | 3',5'-cyclic AMP synthetase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3210 | desoxyribonuclease | Designated preferred name (PT) | NO | |
| RxCUI: 3210 | desoxyribonuclease | Full form of descriptor (FN) | NO | |
| RxCUI: 3210 | desoxyribonuclease | Designated preferred name (PT) | NO | |
| RxCUI: 3210 | desoxyribonuclease | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 3210 | desoxyribonuclease | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3210 | desoxyribonuclease | Full form of descriptor (FN) | NO | |
| RxCUI: 321044 | CD1c - Cluster of differentiation antigen 1c | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 321044 | CD1c - Cluster of differentiation antigen 1c | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 321044 | CD1c - Cluster of differentiation antigen 1c | Designated preferred name (PT) | NO | |
| RxCUI: 321044 | CD1c - Cluster of differentiation antigen 1c | Full form of descriptor (FN) | NO | |
| RxCUI: 321064 | Olmesartan | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 321064 | Olmesartan | Designated preferred name (PT) | YES | |
| RxCUI: 321064 | Olmesartan | Full form of descriptor (FN) | YES | |
| RxCUI: 321064 | Olmesartan | Designated preferred name (PT) | YES | |
| RxCUI: 321064 | Olmesartan | Full form of descriptor (FN) | YES | |
| RxCUI: 3211 | Type I restriction enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3211 | Type I restriction enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3211 | Type I restriction enzyme | Designated preferred name (PT) | NO | |
| RxCUI: 3211 | Type I restriction enzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 321187 | Carbon (11-C) acetate | Designated preferred name (PT) | NO | |
| RxCUI: 321187 | Carbon (11-C) acetate | Full form of descriptor (FN) | NO | |
| RxCUI: 3212 | Type II restriction enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3212 | Type II restriction enzyme | Designated preferred name (PT) | NO | |
| RxCUI: 3212 | Type II restriction enzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 321208 | fondaparinux | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 321208 | fondaparinux | Designated preferred name (PT) | YES | |
| RxCUI: 321208 | fondaparinux | Full form of descriptor (FN) | YES | |
| RxCUI: 321208 | fondaparinux | Designated preferred name (PT) | YES | |
| RxCUI: 321208 | fondaparinux | Full form of descriptor (FN) | YES | |
| RxCUI: 32121 | Purine nucleosidase | Designated preferred name (PT) | NO | |
| RxCUI: 32121 | Purine nucleosidase | Full form of descriptor (FN) | NO | |
| RxCUI: 321213 | Aviptadil | Designated preferred name (PT) | NO | |
| RxCUI: 321213 | Aviptadil | Full form of descriptor (FN) | NO | |
| RxCUI: 321213 | Aviptadil | Designated preferred name (PT) | NO | |
| RxCUI: 321213 | Aviptadil | Full form of descriptor (FN) | NO | |
| RxCUI: 32122 | Nucleoside deoxyribosyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 32122 | Nucleoside deoxyribosyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 32125 | Nucleoside phosphotransferase | Designated preferred name (PT) | NO | |
| RxCUI: 32125 | Nucleoside phosphotransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 32127 | Nucleoside-triphosphate pyrophosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 32127 | Nucleoside-triphosphate pyrophosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 32128 | Nucleoside-triphosphate-adenylate kinase | Designated preferred name (PT) | NO | |
| RxCUI: 32128 | Nucleoside-triphosphate-adenylate kinase | Full form of descriptor (FN) | NO | |
| RxCUI: 3213 | Type III restriction enzyme | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 3213 | Type III restriction enzyme | Designated preferred name (PT) | NO | |
| RxCUI: 3213 | Type III restriction enzyme | Full form of descriptor (FN) | NO | |
| RxCUI: 32130 | Nucleoside-diphosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 32130 | Nucleoside-diphosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 32131 | Nucleoside-triphosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 32131 | Nucleoside-triphosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 32135 | Nucleotide pyrophosphatase | Designated preferred name (PT) | NO | |
| RxCUI: 32135 | Nucleotide pyrophosphatase | Full form of descriptor (FN) | NO | |
| RxCUI: 32136 | Nucleotide pyrophosphokinase | Designated preferred name (PT) | NO | |
| RxCUI: 32136 | Nucleotide pyrophosphokinase | Full form of descriptor (FN) | NO | |
| RxCUI: 321369 | Oraqix | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 32165 | Methylated-deoxyribonucleic acid-protein-cysteine methyltransferase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 32165 | Methylated-deoxyribonucleic acid-protein-cysteine methyltransferase | Full form of descriptor (FN) | NO | |
| RxCUI: 32165 | Methylated-deoxyribonucleic acid-protein-cysteine methyltransferase | Designated preferred name (PT) | NO | |
| RxCUI: 321650 | Product containing iodine and potassium iodide (medicinal product) | Multiple Ingredients (MIN) | Two or more ingredients appearing together in a single drug preparation, created from SCDF. In rare cases when IN/PIN or PIN/PIN combinations of the same base ingredient exist, created from SCD. | YES |
| RxCUI: 321650 | Product containing iodine and potassium iodide (medicinal product) | Designated preferred name (PT) | YES | |
| RxCUI: 321650 | Product containing iodine and potassium iodide (medicinal product) | Full form of descriptor (FN) | YES | |
| RxCUI: 321876 | Thrombin-JMI | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | YES |
| RxCUI: 321898 | Small interfering RNA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 321898 | Small interfering RNA | Designated preferred name (PT) | NO | |
| RxCUI: 321898 | Small interfering RNA | Full form of descriptor (FN) | NO | |
| RxCUI: 321898 | Small interfering RNA | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 321952 | Pimecrolimus (substance) | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 321952 | Pimecrolimus (substance) | Designated preferred name (PT) | YES | |
| RxCUI: 321952 | Pimecrolimus (substance) | Full form of descriptor (FN) | YES | |
| RxCUI: 321952 | Pimecrolimus (substance) | Designated preferred name (PT) | YES | |
| RxCUI: 321952 | Pimecrolimus (substance) | Full form of descriptor (FN) | YES | |
| RxCUI: 321988 | Escitalopram | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 321988 | Escitalopram | Designated preferred name (PT) | YES | |
| RxCUI: 321988 | Escitalopram | Full form of descriptor (FN) | YES | |
| RxCUI: 321988 | Escitalopram | Designated preferred name (PT) | YES | |
| RxCUI: 321988 | Escitalopram | Full form of descriptor (FN) | YES |